Efficacy and safety of liraglutide versus placebo as add-on to glucose-lowering therapy in patients with type 2 diabetes and moderate renal impairment (LIRA-RENAL): a randomized clinical trial
Kataoka, J., Tassone, E., Misso, M., Joham, A., Stener-Victorin, E., Teede, H., & Moran, L
these are the lowest values from cardiovascular outcomes trials of the more common SGLT2is and GLP-1 RAs used in Australia [41, 42]
No major linguistic or cultural issues were identified thus far
Ten preparat wpywa na kolor skry, co moe prowadzi do powstawania ciemniejszych plam, pieprzykw i piegw
GLP-1s, or glucagon-like peptide-1 receptor agonists, are a class of medications that mimic the action of the satiety hormones that naturally occur in our body, says Carolyn Jasik, MD, a board-certified physician in pediatrics and adolescent medicine